Category: Zacks Small Cap Research

1 2 3 24 10 / 233 POSTS
By Brian Marckx, CFANASDAQ:DAREREAD THE FULL DARE RESEARCH REPORTQ2 / Pipeline UpdateDaré (NASDAQ:DARE) continues to not only move their various development programs forward, but also continues to add promising candidates to their high-potential wome ...
By John Vandermosten, CFATSX:RVXOperational UpdateOn September 12, 2018 Resverlogix Corp. (TSX:RVX) held its annual and special meeting of shareholders which included a presentation by CEO Don McCaffrey. The presentation updated investors on the tria ...
NASDAQ:SRAXLos Angeles, California-based Social Reality, Inc. (NASDAQ:SRAX) is a technology company focused on the digital advertising market, which Adweek pegs at $83 billion, including aggregating consumer data to facilitate online marketing. Lever ...
By John Vandermosten, CFANASDAQ:TTNPREAD THE FULL TTNP RESEARCH REPORTSecond Quarter 2018 Financial and Operational ResultsTitan Pharmaceuticals, Inc. (NASDAQ:TTNP) reported second quarter 2018 results in its August 14th release and subsequently file ...
NASDAQ:CKPTYesterday, Checkpoint Therapeutics (NASDAQ:CKPT) announced preliminary safety and efficacy data from their ongoing Phase I/II trial for CK-101. CK-101 is the company’s most advanced candidate intended for non-small cell lung cancer (NSCLC) ...
By David Bautz, PhDNASDAQ:MTPREAD THE FULL MTP RESEARCH REPORT HEREBusiness UpdateMidatech Pharma Plc (NASDAQ:MTP) is a specialty pharmaceutical company with three novel drug delivery technologies that improve bio-distribution and bio-delivery of dru ...
By Brian Marckx, CFANASDAQ:BMRAREAD THE FULL BMRA RESEARCH REPORTQ4 2018: Legacy Biz Slows in Q4.Operational Highlights Include InFoods Enrolling, Ex-Walgreens CMO Joins SAB (and we’re intrigued)… Biomerica (NASDAQ:BMRA) reported financial results fo ...
NYSE:JTBeijing, China-based Jianpu Technology Inc.  (NYSE:JT) is an internet services provider that operates an open platform enabling individual users and small businesses to obtain information about selecting financial services and products and als ...
By David Bautz, PhDNASDAQ:BVXVREAD THE FULL BVXV RESEARCH REPORTBusiness UpdateFirst Subject Enrolled in Phase 3 Trial of M-001BiondVax Pharmaceuticals,Ltd. (NASDAQ:BVXV) is a biopharmaceutical company developing a universal influenza vaccine (M-001) ...
By David Bautz, PhDTSX:ATE.VREAD THE FULL ATE.V RESEARCH REPORTBusiness UpdateScientific Report on Phase 2b Trial of ATB-346On August 29, 2018, Antibe Therapeutics, Inc. (TSX:ATE.V) announced the availability of a comprehensive report summarizing the ...
1 2 3 24 10 / 233 POSTS